RARECHEM AM UC 0304
CAS2419-68-3
RARECHEM AM UC 0304 (CAS 2419-68-3, C14H16O3) is supplied by ChemSigma for research and manufacturing, with specification, analytical methods and batch documentation available on request.
- CAS No.
- 2419-68-3
- Formula
- C14H16O3
- Mol. weight
- 232.28 g/mol
Chemical Specifications
Identifiers
| CAS number | 2419-68-3 |
|---|---|
| Product name | RARECHEM AM UC 0304 |
| Synonyms | RARECHEM AM UC 0304; 1-(3,4-METHYLENEDIOXY-PHENYL)-4,4-DIMETHYL-PENT-1-EN-3-ONE; 1-(3,4-METHYLENEDIOXY-BENZYLIDENE)-3,3-DIMETHYLBUT-2-ONE; 4,4-DiMethyl-1-(3,4-Methylenedioxyphenyl)-1-penten-3-one; 4,4-DiMethyl-1-[3,4-(Methylenedioxy)phenyl]-1-penten-3-one |
| Molecular formula | C14H16O3 |
| Molecular weight | 232.28 g/mol |
Packaging, Storage & Transport
| Available pack sizes | 5kg, 1kg, 500g, 100g, 50g, 10g |
|---|
Read the current safety data sheet before handling. Packaging can be adapted to the order quantity and destination.
Frequently Asked Questions
What is the CAS number of RARECHEM AM UC 0304?
The CAS Registry Number of RARECHEM AM UC 0304 is 2419-68-3. RARECHEM AM UC 0304 is also known as RARECHEM AM UC 0304; 1-(3,4-METHYLENEDIOXY-PHENYL)-4,4-DIMETHYL-PENT-1-EN-3-ONE; 1-(3,4-METHYLENEDIOXY-BENZYLIDENE)-3,3-DIMETHYLBUT-2-ONE.
What is the molecular formula and molecular weight of RARECHEM AM UC 0304?
The molecular formula of RARECHEM AM UC 0304 is C14H16O3, and its molecular weight is 232.28 g/mol.
How can I request a quotation for RARECHEM AM UC 0304?
Send an inquiry for RARECHEM AM UC 0304 (CAS 2419-68-3) with the required quantity, target specification, destination country and any documentation requirements. ChemSigma will confirm availability, packaging, lead time and price.
Request a Quote for RARECHEM AM UC 0304
Tell us the required quantity, target specification, destination country and any documentation requirements. We will confirm availability, packaging, lead time and price.
Need custom synthesis or scale-up? Our group company CKS Technology offers custom synthesis, process development and scale-up.